Alzheimer drug hits India priced near 1 lakh per dose raises access alarms

Once a month for up to 18 months

A prescription-only intravenous Alzheimer’s treatment has launched in India at Rs 91,688 for a 350 mg vial. The monthly therapy can be given for up to 18 months, making the total cost potentially steep for many patients. The drug targets the underlying disease process linked to amyloid plaque buildup and neurofibrillary tangles in the brain.